Home » Topics » BioWorld Science

BioWorld Science
RSS

Tiziana in license agreement with BWH for neurodegenerative diseases

April 16, 2018

Shire agrees to sell oncology business to Servier

April 16, 2018

Chugai Pharmaceutical presents new GLP-1 receptor agonists

April 16, 2018

Gilead divulges new PI3K inhibitors

April 16, 2018

Telix establishes research partnership to study use of its clinical targeting agents with astatine

April 16, 2018

DGMIF identifies novel WEE1hu inhibitors

April 16, 2018

Bayer presents adenosine A2B receptor antagonists and IL-6 release inhibitors

April 16, 2018

First phase I data reported for heptatis B virus candidate RO-7049389

April 16, 2018

Eusol initiates phase III study of ES-135 in patients with spinal cord injury

April 16, 2018

Pfizer presents data on ACC inhibitor PF-05221304

April 16, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 11, 2025.
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...